lactic acid has been researched along with imatinib mesylate in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ariel, G; Benny, O; Black, PM; Carroll, RS; Goren, E; Kim, SK; Machluf, M; Menon, LG; Stewman, C | 1 |
| Anderson, N; Christians, U; Eckhardt, SG; Klawitter, J; Leibfritz, D; Serkova, NJ | 1 |
| Brown, JL; Christians, U; Eckhardt, SG; Klawitter, J; Kominsky, DJ; Leibfritz, D; Melo, JV; Serkova, NJ | 1 |
| Dafni, H; Hu, S; Larson, PE; Ronen, SM; Venkatesh, HS; Vigneron, DB; Wang, C; Ward, CS; Yoshihara, HA; Zhang, X | 1 |
| Akgun, E; Avsar, T; Baysal, K; Karal-Yilmaz, O; Kilic, T; Kukut, M; Ozkan, A | 1 |
| Augustyniak, D; Bartkowiak, A; Goffeau, A; Gonchar, M; Ko, YH; Lis, P; Majkowska-Skrobek, G; Pedersen, PL; Ułaszewski, S | 1 |
| Chen, W; Hennink, WE; Kiessling, F; Kok, RJ; Lammers, T; Ramazani, F; Storm, G; Van Nostrum, CF | 1 |
| Ahmad, FJ; Khan, AM; Panda, AK; Talegaonkar, S | 1 |
| Cardoso, HJ; Carvalho, TMA; Figueira, MI; Socorro, S; Vaz, CV | 1 |
| De Rosa, V; Del Vecchio, S; Fonti, R; Iommelli, F; Monti, M; Terlizzi, C | 1 |
| Gayatri, MB; Gundeti, S; Kancha, RK; Patchva, D; Reddy, ABM; Velugonda, N | 1 |
12 other study(ies) available for lactic acid and imatinib mesylate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth.
Topics: Animals; Benzamides; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Glioma; Humans; Imatinib Mesylate; Lactic Acid; Male; Mice; Mice, Inbred C57BL; Microspheres; Phosphorylation; Piperazines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Xenograft Model Antitumor Assays | 2009 |
Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Cell Proliferation; Chromatography, High Pressure Liquid; Fatty Acids; Fusion Proteins, bcr-abl; Glucose; Humans; Imatinib Mesylate; K562 Cells; Kinetics; Lactic Acid; Leukemia; Magnetic Resonance Spectroscopy; Phospholipids; Phosphorylation; Piperazines; Pyrimidines; Time Factors | 2009 |
Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Flow Cytometry; Glycolysis; Humans; Imatinib Mesylate; K562 Cells; Lactic Acid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Spectroscopy; Phospholipids; Piperazines; Pyrimidines | 2009 |
Hyperpolarized 13C spectroscopic imaging informs on hypoxia-inducible factor-1 and myc activity downstream of platelet-derived growth factor receptor.
Topics: Animals; Benzamides; Capillary Permeability; Carbon Isotopes; Humans; Hypoxia-Inducible Factor 1; Imatinib Mesylate; L-Lactate Dehydrogenase; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Paclitaxel; Piperazines; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Vascular Endothelial Growth Factor A | 2010 |
Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis.
Topics: Antineoplastic Agents; Benzamides; Chromatography, High Pressure Liquid; Craniopharyngioma; Imatinib Mesylate; Lactic Acid; Microspheres; Neovascularization, Pathologic; Piperazines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Spectrophotometry, Ultraviolet | 2013 |
Killing multiple myeloma cells with the small molecule 3-bromopyruvate: implications for therapy.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Benzamides; Buthionine Sulfoximine; Cell Survival; Glutathione; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Lactic Acid; Monocarboxylic Acid Transporters; Multiple Myeloma; Piperazines; Pyrimidines; Pyruvates; Symporters; Tumor Cells, Cultured | 2014 |
Formulation and characterization of microspheres loaded with imatinib for sustained delivery.
Topics: Delayed-Action Preparations; Drug Carriers; Drug Liberation; Imatinib Mesylate; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Time Factors | 2015 |
Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
Topics: Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Glioblastoma; Humans; Imatinib Mesylate; Lactic Acid; Nanoparticles; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Tyrosine kinase inhibitor imatinib modulates the viability and apoptosis of castrate-resistant prostate cancer cells dependently on the glycolytic environment.
Topics: Apoptosis; Cell Proliferation; Glucose; Glycolysis; Humans; Hyperglycemia; Imatinib Mesylate; Lactic Acid; Male; Prostatic Neoplasms, Castration-Resistant; Protein Kinase Inhibitors; Tumor Cells, Cultured | 2019 |
Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells.
Topics: Antineoplastic Agents; Caspase 3; Cell Line, Tumor; Cyclin D1; Glycolysis; Humans; Imatinib Mesylate; Lactic Acid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; Oxidative Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-myc; STAT3 Transcription Factor | 2019 |
Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia.
Topics: Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Glucose; Humans; Imatinib Mesylate; Lactic Acid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytes, Mononuclear; Metformin | 2023 |